TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

Artificial intelligence-derived 3-Way Concentration-dependent Antagonism of Gatifloxacin, Pyrazinamide, and Rifampicin During Treatment of Pulmonary Tuberculosis.

Jotam G Pasipanodya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.